BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 24365373)

  • 21. Monoclonal Gammopathies of 'Neurological Significance': Paraproteinemic Neuropathies.
    Mani AM; Devasia AJ; Nair A; Benjamin RN; Prabhakar AT; Sivadasan A; Mathew V; Aaron S; George B; Alexander M
    Can J Neurol Sci; 2021 Sep; 48(5):616-625. PubMed ID: 33397535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic criteria of multiple myeloma.
    Kyle RA
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraproteinaemic neuropathies.
    Miescher GC; Steck AJ
    Baillieres Clin Neurol; 1996 Mar; 5(1):219-32. PubMed ID: 8732209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropathy and monoclonal gammopathy.
    Nobile-Orazio E
    Handb Clin Neurol; 2013; 115():443-59. PubMed ID: 23931795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Peripheral neuropathy with monoclonal gammopathy].
    Meier T; Meyer M
    Schweiz Med Wochenschr; 1990 Mar; 120(12):417-25. PubMed ID: 2157280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
    Kyle RA; Therneau TM; Rajkumar SV; Offord JR; Larson DR; Plevak MF; Melton LJ
    N Engl J Med; 2002 Feb; 346(8):564-9. PubMed ID: 11856795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
    Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
    Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma.
    Kyle RA
    Hematol Oncol Clin North Am; 1997 Feb; 11(1):71-87. PubMed ID: 9081205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dealing with neuropathy in plasma-cell dyscrasias.
    Sonneveld P; Jongen JL
    Hematology Am Soc Hematol Educ Program; 2010; 2010():423-30. PubMed ID: 21239830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acquired peripheral neuropathies associated with monoclonal gammopathy].
    Gajos A; Kieliś W; Szadkowska I; Chmielowska E; Niewodniczy A; Bogucki A
    Neurol Neurochir Pol; 2007; 41(2):169-75. PubMed ID: 17530580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.
    International Myeloma Working Group
    Br J Haematol; 2003 Jun; 121(5):749-57. PubMed ID: 12780789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Skin disorders associated with monoclonal gammopathies].
    Houtman CJ; Genders RE; von dem Borne PA; Vermeer MH
    Ned Tijdschr Geneeskd; 2014; 158():A6717. PubMed ID: 24780569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
    Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
    Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac amyloidoma with IgM-kappa gammopathy.
    Warner KJ; Blackwell GG; Herrera GA; Listinsky C; Holman WL; Rustagi PK
    Arch Pathol Lab Med; 1994 Nov; 118(11):1148-50. PubMed ID: 7979903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
    Kamezaki K; Nagafuji K
    Nihon Rinsho; 2007 Dec; 65(12):2235-7. PubMed ID: 18069266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
    Kelly JJ
    Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
    Steiner N; Schwärzler A; Göbel G; Löscher W; Wanschitz J; Gunsilius E
    Oncotarget; 2017 Jan; 8(3):5081-5091. PubMed ID: 27974705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory and clinical characterization of monoclonal gammopathy in Taiwanese.
    Lee LN; Jan IS; Tien HF; Lin JS; Lo SC; Cheng WC
    J Formos Med Assoc; 2002 Feb; 101(2):91-7. PubMed ID: 12099210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pitfalls of monoclonal gammopathy].
    Meuleman N
    Rev Med Brux; 2013 Sep; 34(4):335-8. PubMed ID: 24195249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal gammopathies of undetermined significance.
    Kyle RA; Rajkumar SV
    Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.